MA28980B1 - 1, 1, 2, 2-tetra (hetero) arylethanes ou 1, 1, 2-tri (hetero) aryle-2-heterocyclylethanes comme inhibiteurs des canaux potassiques - Google Patents

1, 1, 2, 2-tetra (hetero) arylethanes ou 1, 1, 2-tri (hetero) aryle-2-heterocyclylethanes comme inhibiteurs des canaux potassiques

Info

Publication number
MA28980B1
MA28980B1 MA29689A MA29689A MA28980B1 MA 28980 B1 MA28980 B1 MA 28980B1 MA 29689 A MA29689 A MA 29689A MA 29689 A MA29689 A MA 29689A MA 28980 B1 MA28980 B1 MA 28980B1
Authority
MA
Morocco
Prior art keywords
hetero
inhibitors
heterocyclylethanes
arylethanes
tetra
Prior art date
Application number
MA29689A
Other languages
English (en)
Inventor
Mark T Bilodeau
Zhicai Wu
John Hartnett
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of MA28980B1 publication Critical patent/MA28980B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cette invention porte sur des composés représentés par la structure (1) utiles en tant qu'inhibiteurs de canal potassique dans le traitement des arythmies cardiaques et autres maladies similaires.
MA29689A 2004-07-29 2007-02-21 1, 1, 2, 2-tetra (hetero) arylethanes ou 1, 1, 2-tri (hetero) aryle-2-heterocyclylethanes comme inhibiteurs des canaux potassiques MA28980B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59218104P 2004-07-29 2004-07-29

Publications (1)

Publication Number Publication Date
MA28980B1 true MA28980B1 (fr) 2007-11-01

Family

ID=35613661

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29689A MA28980B1 (fr) 2004-07-29 2007-02-21 1, 1, 2, 2-tetra (hetero) arylethanes ou 1, 1, 2-tri (hetero) aryle-2-heterocyclylethanes comme inhibiteurs des canaux potassiques

Country Status (15)

Country Link
KR (1) KR20070043985A (fr)
AR (1) AR049847A1 (fr)
BR (1) BRPI0513793A (fr)
CR (1) CR8876A (fr)
EC (1) ECSP077208A (fr)
IL (1) IL180846A0 (fr)
MA (1) MA28980B1 (fr)
MX (1) MX2007001188A (fr)
NO (1) NO20071107L (fr)
PE (1) PE20060382A1 (fr)
RU (1) RU2344134C2 (fr)
TW (1) TW200607493A (fr)
UA (1) UA88018C2 (fr)
WO (1) WO2006028590A1 (fr)
ZA (1) ZA200700477B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1009313A2 (pt) * 2009-03-18 2018-01-30 Medicure Int Inc preparação farmacêutica transdérmica e administração de tirofiban
BR112014030629B1 (pt) 2012-06-11 2021-12-21 Bristol-Myers Squibb Company Prófármacos de ácido fosforamídico de 5-[5-fenil-4-(piridin-2-ilmetilamino) quinazolin -2-il] piridina-3-sulfonamida e composição farmacêutica que os compreende

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003201273A1 (en) * 2002-01-04 2003-07-30 Poseidon Pharmaceuticals A/S Potassium channel modulators

Also Published As

Publication number Publication date
NO20071107L (no) 2007-04-19
ZA200700477B (en) 2009-08-26
CR8876A (es) 2007-08-28
WO2006028590A1 (fr) 2006-03-16
RU2344134C2 (ru) 2009-01-20
KR20070043985A (ko) 2007-04-26
IL180846A0 (en) 2007-06-03
RU2007107408A (ru) 2008-09-10
PE20060382A1 (es) 2006-05-15
ECSP077208A (es) 2007-02-28
BRPI0513793A (pt) 2008-05-13
UA88018C2 (ru) 2009-09-10
TW200607493A (en) 2006-03-01
MX2007001188A (es) 2007-03-21
AR049847A1 (es) 2006-09-06

Similar Documents

Publication Publication Date Title
MA31906B1 (fr) Inhibiteurs de la replication du virus de limmunodeficience humaine
MA29817B1 (fr) Derives de prolinamide utilises comme modulateurs du canal sodium
EA200802213A1 (ru) Способы лечения заболеваний крови
DE602004022633D1 (de) 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
MA30427B1 (fr) Derives bicycliques utilises comme inhibiteurs de cetp
PT1543011E (pt) Composto de tienopirrolilo e furanopirrolilo e sua utilizacao como ligandos do receptor h4 da histamina
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
EA201370001A1 (ru) Противовирусные составы для местного применения
MY139690A (en) Sulfonamide derivatives for the treatment of diseases.
MY143390A (en) Sulfonamide derivatives for the treatment of diseases.
EA200700934A1 (ru) Производные пиримидина и их применение в качестве модуляторов cb2
EA200301232A1 (ru) Новые соединения арилсульфонамида и их применение для лечения ожирения, диабета типа ii и нарушений центральной нервной системы
EP1673078A4 (fr) Inhibiteurs de type benzylether et benzylamino de beta-secretase pour le traitement de la maladie d'alzheimer
BRPI0508537A (pt) moduladores do canal de ìon
DE60118003D1 (de) Harnstoffderivate und ihre verwendung
PT1206474E (pt) Compostos de sulfonilfenilpirazole uteis como inibidores de cox-2
MA31167B1 (fr) Inhibiteurs de l'activite de akt
WO2006004741A3 (fr) 3-aminocyclopentanecarboxamides utilises en tant que modulateurs des recepteurs des chimiokines
NO20060278L (no) Piperazinderivater og fremgangsmater for anvendelse
MXPA05009535A (es) Compuestos de acido n - alquil - hidroxamico - isoindolilo y sus usos farmaceuticos.
BR0314053A (pt) Pirazolopiridinas e métodos de obtenção e uso das mesmas
EA200601217A1 (ru) Новые конденсированные пирролокарбазолы
EA200601219A1 (ru) Новые конденсированные пирролокарбазолы
BRPI0411085A (pt) composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de vìrus oncogênicos, e de condições ou distúrbios devidos a infecção por hpv